fda to reconsider tirzepatide removal of Eli Lilly weight loss drug from shortage list FDA Approves Diabetes Drug Tirzepatide

GLP-1 friendly meals are best suited for individuals who want to enhance their metabolic health, manage weight, and control blood sugar, particularly those using or considering GLP-1 medications

Chelation agents are designed to bind to and remove metals like copper

In 2025, the World Health Organisation added semaglutide and other GLP-1 medicines to its Model List of Essential Medicines for selected patients with type 2 diabetes who also have cardiovascular disease, chronic kidney disease or obesity

A collaborative approach with your healthcare provider is paramount for making informed decisions regarding treatment

Conflict of interest The named authors have no conflicts of interest, financial or otherwise

Compounded medications are not FDA-approved, and the FDA does not review them before sale for safety, effectiveness, potency, sterility, or manufacturing quality